NCT04468971View on ClinicalTrials.gov

REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

October 22, 2021

Study Completion Date

October 22, 2021

Conditions
COVID19ARDS
Interventions
BIOLOGICAL

CK0802

Cryopreserved, off the shelf, cord blood derived T regulatory cells

DRUG

Placebo

Expicient

Trial Locations (5)

10027

Columbia University, New York

21287

Johns Hopkins Hospital, Baltimore

27157

Wake Forest University, Winston-Salem

27514

University of North Carolina, Chapel Hill

77005

Baylor College of Medicine, St Luke's Hospital, Houston

Sponsors

Lead Sponsor

Cellenkos, Inc.
All Listed Sponsors
lead

Cellenkos, Inc.

INDUSTRY